Friday, May 18, 2012

Intranasal Drug Delivery Developments

This allergy season, keep an eye on new developments in the intranasal drug delivery world that are rapidly changing, from the drugs offered to how its administered. Researches are saying that drugs administered the intranasal route are not only efficient, but also highly effective. Empirical studies reveal adequate pain relief when drugs are administered intranasally. Several intranasal pain management drugs have been developed fortreating postoperative pain, chronic and acute pains (arthritis), andmigraines.

In addition to treating common ailments, such as nasal congestion, application of intranasal drug administration is expanding to include treatment of allergies,osteoporosis, pain management, vitamin B12 deficiency, smoking cessation,migraines, and nocturnal enuresis. Some are also saying that  Bi-directional drug delivery is perhaps the most efficient  way to deliver a drug. Bi-directional nasal device offers two major advantages,namely restricting the entry of smaller particles into the lungs, and enabling easy airflow inside the nose. With nasal sprays and inhalers, often times air can either escape or allow unwanted particles in. Bi-directional delivery would help avoid that problem. What do you think about the use of intranasal drug delivery for non-allergy related medication?

Want to learn more about Drug Delivery? The Drug Delivery Partnerships conference will take place February 6-8, 2013 in San Diego, Ca. o view the recap on the 2012 Executive Summary, download it here.

No comments:

Post a Comment